Methyprylon: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
== Methyprylon == | |||
[[File:Methyprylon_structure.svg|Methyprylon chemical structure|thumb|right]] | |||
Methyprylon | '''Methyprylon''' is a [[sedative]] and [[hypnotic]] medication that was primarily used in the mid-20th century for the treatment of [[insomnia]]. It belongs to the class of drugs known as [[pyrimidinediones]], which are structurally related to [[barbiturates]]. Methyprylon was marketed under various brand names, including [[Noludar]]. | ||
== Pharmacology == | == Pharmacology == | ||
Methyprylon works by | Methyprylon acts as a central nervous system [[depressant]]. It works by enhancing the activity of the [[gamma-aminobutyric acid]] (GABA) neurotransmitter, which is the primary inhibitory neurotransmitter in the brain. This action results in a calming effect on the brain, making it easier for individuals to fall asleep. | ||
The drug has a relatively short half-life, which means it is eliminated from the body more quickly than some other sedatives. This property made it useful for patients who needed help falling asleep but did not want to experience lingering sedative effects the following day. | |||
== Medical Uses == | |||
Methyprylon was primarily prescribed for the short-term management of [[insomnia]]. It was particularly useful for patients who had difficulty falling asleep. However, due to the development of newer and safer [[hypnotic]] agents, the use of methyprylon has declined significantly. | |||
== Side Effects == | |||
Common side effects of methyprylon included [[drowsiness]], [[dizziness]], and [[headache]]. More serious side effects could include [[respiratory depression]], especially when taken in high doses or in combination with other central nervous system depressants such as [[alcohol]]. | |||
== Overdose == | |||
Overdose of methyprylon can lead to severe [[central nervous system depression]], [[respiratory failure]], and even [[death]]. Symptoms of overdose may include extreme drowsiness, confusion, [[hypotension]], and [[coma]]. | |||
== Discontinuation == | |||
Methyprylon was withdrawn from the market in many countries due to concerns about its safety and the availability of safer alternatives. The risk of [[dependence]] and [[abuse]] associated with methyprylon also contributed to its decline in use. | |||
== | == Chemical Properties == | ||
[[File:Methyprylon_ball-and-stick.png|Methyprylon ball-and-stick model|thumb|left]] | |||
Methyprylon is a [[pyrimidinedione]] derivative. Its chemical structure is characterized by a pyrimidine ring, which is a six-membered ring containing two nitrogen atoms. The presence of this ring is what gives methyprylon its sedative properties. | |||
== | == Related Pages == | ||
* [[Barbiturate]] | * [[Barbiturate]] | ||
* [[ | * [[Hypnotic]] | ||
* [[ | * [[Sedative]] | ||
* [[Insomnia]] | |||
[[Category:Sedatives]] | [[Category:Sedatives]] | ||
[[Category:Hypnotics]] | [[Category:Hypnotics]] | ||
[[Category: | [[Category:Withdrawn drugs]] | ||
Latest revision as of 11:23, 23 March 2025
Methyprylon[edit]
Methyprylon is a sedative and hypnotic medication that was primarily used in the mid-20th century for the treatment of insomnia. It belongs to the class of drugs known as pyrimidinediones, which are structurally related to barbiturates. Methyprylon was marketed under various brand names, including Noludar.
Pharmacology[edit]
Methyprylon acts as a central nervous system depressant. It works by enhancing the activity of the gamma-aminobutyric acid (GABA) neurotransmitter, which is the primary inhibitory neurotransmitter in the brain. This action results in a calming effect on the brain, making it easier for individuals to fall asleep.
The drug has a relatively short half-life, which means it is eliminated from the body more quickly than some other sedatives. This property made it useful for patients who needed help falling asleep but did not want to experience lingering sedative effects the following day.
Medical Uses[edit]
Methyprylon was primarily prescribed for the short-term management of insomnia. It was particularly useful for patients who had difficulty falling asleep. However, due to the development of newer and safer hypnotic agents, the use of methyprylon has declined significantly.
Side Effects[edit]
Common side effects of methyprylon included drowsiness, dizziness, and headache. More serious side effects could include respiratory depression, especially when taken in high doses or in combination with other central nervous system depressants such as alcohol.
Overdose[edit]
Overdose of methyprylon can lead to severe central nervous system depression, respiratory failure, and even death. Symptoms of overdose may include extreme drowsiness, confusion, hypotension, and coma.
Discontinuation[edit]
Methyprylon was withdrawn from the market in many countries due to concerns about its safety and the availability of safer alternatives. The risk of dependence and abuse associated with methyprylon also contributed to its decline in use.
Chemical Properties[edit]
Methyprylon is a pyrimidinedione derivative. Its chemical structure is characterized by a pyrimidine ring, which is a six-membered ring containing two nitrogen atoms. The presence of this ring is what gives methyprylon its sedative properties.
